Avecho Biotechnology Ltd has released a press release.
Receipt of $2.4m R&D Tax Incentive
Filed with ASX ·
6ix hasn’t read this filing yet.
Avecho Biotechnology Limited on 6ix
Earlier from Avecho Biotechnology
- Phosphagenics Announces Results of TPM/Oxycodone Ph2a Trial
- R & D Taxation Incentive
- Positive Results for Weaner Pig Feed Efficiency Trial
- POH to Proceed with Twice Weekly Oxycodone Patch Development
- POH Signs Further Deed of Settlement with Final Parties
Later from Avecho Biotechnology
- December 2013 Appendix 4E - Annual Financial Report
- Enrolments Completed for Phase 2 Acne Treatment Trial
- June 2014 App 4D Half Yearly Report and Financial Report
- Opioid Patch Program Update
- Oxymorphone Pain Relief Patch - Multi-Dose Trial
Follow Avecho Biotechnology into a list and get an email when it puts out news.
Follow Avecho Biotechnology